Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion type Assertion NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_head.
- NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion description "[Among them, miR-137, miR-124-2, miR-124-3, and miR-9-3 were frequently and tumor-specifically methylated in primary cancers (miR-137: 68.7%; miR-124-2: 50.6%; miR-124-3: 65.1%; miR-9-3: 45.8%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_provenance.
- NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion evidence source_evidence_literature NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_provenance.
- NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion SIO_000772 23200812 NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_provenance.
- NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion wasDerivedFrom befree-20150227 NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_provenance.
- NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_assertion wasGeneratedBy ECO_0000203 NP993004.RAFNp6gpro_Jzc_R1a4wShrPkELGutYsTI2of9tYkrtgI130_provenance.